Urban Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Urban Wealth Management's VRTX Position: Q2 2026 in Review
Urban Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, selling an estimated $59.8K and leaving 856 shares worth $425K. The position accounts for 0.37% of the portfolio, ranked #59.
Urban Wealth Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $443K in Q1 2026. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Urban Wealth Management held 856 shares of Vertex Pharmaceuticals worth $425K as of Q2 2026.
- Urban Wealth Management sold 135 Vertex Pharmaceuticals shares in Q2 2026, an estimated $59.8K.
- Vertex Pharmaceuticals made up 0.37% of Urban Wealth Management's portfolio in Q2 2026, its #59 holding.
- Urban Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Urban Wealth Management's Vertex Pharmaceuticals position peaked at $443K in Q1 2026.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Urban Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.